| 1st Sep 2023 7:00 am |
RNS |
GSK’s Nucala CRSwNP submission accepted in Japan |
| 31st Aug 2023 3:16 pm |
RNS |
Holding(s) in Company |
| 31st Aug 2023 3:14 pm |
RNS |
Holding(s) in Company |
| 25th Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Aug 2023 7:00 am |
RNS |
Shingrix data demonstrate 100% efficacy in China |
| 22nd Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 10th Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 9th Aug 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 8th Aug 2023 1:05 pm |
RNS |
Publication of Base Prospectus |
| 1st Aug 2023 3:00 pm |
RNS |
Total Voting Rights |
| 31st Jul 2023 6:00 pm |
RNS |
FDA approves new use for Jemperli plus chemo |
| 31st Jul 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 28th Jul 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 26th Jul 2023 7:00 am |
RNS |
2nd Quarter Results |
| 24th Jul 2023 7:00 am |
RNS |
Cabotegravir LA for PrEP receives positive CHMP |
| 20th Jul 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 17th Jul 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jul 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 3rd Jul 2023 3:00 pm |
RNS |
Total Voting Rights |
| 28th Jun 2023 3:43 pm |
RNS |
GSK completes acquisition of BELLUS Health |
| 27th Jun 2023 7:00 am |
RNS |
FDA Fast Track for Gonorrhoea Vaccine Candidate |
| 26th Jun 2023 7:05 am |
RNS |
Shingrix approved in Japan for adults 18 and over |
| 26th Jun 2023 7:00 am |
RNS |
GSK daprodustat gains positive EMA CHMP opinion |
| 23rd Jun 2023 3:37 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Jun 2023 3:33 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Jun 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Jun 2023 7:00 am |
RNS |
Statement: Zantac (ranitidine) litigation |
| 22nd Jun 2023 7:00 am |
RNS |
GSK’s Arexvy recommended by ACIP |
| 21st Jun 2023 7:00 am |
RNS |
Season two data for GSK Arexvy RSV OA vaccine |
| 16th Jun 2023 7:00 am |
RNS |
Extension of FDA review period for momelotinib |
| 12th Jun 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 7th Jun 2023 7:00 am |
RNS |
EU authorisation of GSK’s RSV vaccine Arexvy |
| 6th Jun 2023 7:00 am |
RNS |
GSK receives US FDA file acceptance for Jemperli |
| 1st Jun 2023 3:00 pm |
RNS |
Total Voting Rights |
| 22nd May 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 16th May 2023 2:00 pm |
RNS |
Holding(s) in Company |
| 15th May 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 15th May 2023 3:00 pm |
RNS |
Block listing Interim Review |
| 12th May 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
